Correlation Between Memscap Regpt and Maat Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Memscap Regpt and Maat Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memscap Regpt and Maat Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Memscap Regpt and Maat Pharma SA, you can compare the effects of market volatilities on Memscap Regpt and Maat Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memscap Regpt with a short position of Maat Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memscap Regpt and Maat Pharma.

Diversification Opportunities for Memscap Regpt and Maat Pharma

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Memscap and Maat is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Memscap Regpt and Maat Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maat Pharma SA and Memscap Regpt is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memscap Regpt are associated (or correlated) with Maat Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maat Pharma SA has no effect on the direction of Memscap Regpt i.e., Memscap Regpt and Maat Pharma go up and down completely randomly.

Pair Corralation between Memscap Regpt and Maat Pharma

Assuming the 90 days trading horizon Memscap Regpt is expected to generate 1.52 times more return on investment than Maat Pharma. However, Memscap Regpt is 1.52 times more volatile than Maat Pharma SA. It trades about 0.08 of its potential returns per unit of risk. Maat Pharma SA is currently generating about 0.01 per unit of risk. If you would invest  91.00  in Memscap Regpt on August 27, 2024 and sell it today you would earn a total of  247.00  from holding Memscap Regpt or generate 271.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Memscap Regpt  vs.  Maat Pharma SA

 Performance 
       Timeline  
Memscap Regpt 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Memscap Regpt has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Maat Pharma SA 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Maat Pharma SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maat Pharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Memscap Regpt and Maat Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Memscap Regpt and Maat Pharma

The main advantage of trading using opposite Memscap Regpt and Maat Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memscap Regpt position performs unexpectedly, Maat Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maat Pharma will offset losses from the drop in Maat Pharma's long position.
The idea behind Memscap Regpt and Maat Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum